Background: It is unknown if a survival gap remains between HIV-infected and HIV-
uninfected individuals with access to care. Methods: We conducted a cohort study within …

Infectious diseases are important causes of morbidity and mortality in patients with cancer.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and …

People living with human immunodeficiency virus (HIV) are living longer since the advent of
effective combined antiretroviral therapy (cART). While cART substantially decreases the …

Malignancies represent a major cause of morbidity and mortality in human
immunodeficiency virus (HIV)-infected patients. The introduction of combined antiretroviral …

HIV infection leads to age-related conditions in relatively young persons. HIV-associated
neurocognitive disorders (HAND) are considered among the most prevalent of these …

Background In the Strategic Timing of Antiretroviral Treatment (START) study, immediate
combination antiretroviral therapy (cART) initiation reduced cancer risk by 64%. We …

Background: Evidence is conflicting about the association of abacavir use and
cardiovascular disease (CVD) among HIV-infected individuals. Previous studies may have …

The role of HIV/AIDS in non-melanoma skin cancer (NMSC) is not well defined. We sought
to update the evidence of the association between HIV/AIDS and risk of NMSC by gender …

Pulmonary complications remain among the most frequent causes of morbidity and mortality
for individuals with HIV despite the advent of antiretroviral therapy (ART) and improvement …

It is unclear whether HIV-infected individuals remain at higher risk of invasive pneumococcal
disease (IPD) compared with HIV-uninfected individuals. We conducted a cohort study of …